YU91790A - Postopek za pripravo substituiranih aminoalkilfosfinskih kislin - Google Patents

Postopek za pripravo substituiranih aminoalkilfosfinskih kislin

Info

Publication number
YU91790A
YU91790A YU91790A YU91790A YU91790A YU 91790 A YU91790 A YU 91790A YU 91790 A YU91790 A YU 91790A YU 91790 A YU91790 A YU 91790A YU 91790 A YU91790 A YU 91790A
Authority
YU
Yugoslavia
Prior art keywords
denotes
hydrogen
substituted
acids
halogen
Prior art date
Application number
YU91790A
Other languages
English (en)
Original Assignee
Ciba-Geigy Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba-Geigy Ag. filed Critical Ciba-Geigy Ag.
Priority to SI9010917A priority Critical patent/SI9010917B/sl
Publication of YU91790A publication Critical patent/YU91790A/sh
Priority to HRP-917/90A priority patent/HRP940178A2/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/36Amides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301Acyclic saturated acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Luminescent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)

Abstract

POSTOPEK ZA PRIPRAVO SUBSTITUIRANIH AMINOALKILFOSFINSKIH KISLIN. P-substituirane aminoalkilfosfinske kisline s formulo kjer R označuje v danem primeru fluorirano metilno skupino, R1 označuje vodik, nižji alkil, nižji alkoksi, hidroksi, halogen ali fluorirano metilno skupino in R2 in R3 označujeta vodik, ali R2 označuje hidroksi, nižji alkoksi ali halogen in je R3 vodik, ali R2 in R3 skupaj predstavljata okso skupino, in njihove farmacevtsko sprejemljive soli, so učinkovite kot GABAb agonisti in se jih da uporabiti pri zdravljenju spinalne spastičnosti, multiple skleroze in cerebralne paralize, nevralgije trigeminusa, sindromov pri odvajanju od drog in/ali bolečinskih stanj. Da se jih pripraviti po samih po sebi znanih metodah in opisane so prikladne tovrstne metode.
YU91790A 1989-05-13 1990-05-10 Postopek za pripravo substituiranih aminoalkilfosfinskih kislin YU91790A (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI9010917A SI9010917B (sl) 1989-05-13 1990-05-10 Postopek za pripravo substituiranih aminoalkilfosfinskih kislin
HRP-917/90A HRP940178A2 (en) 1989-05-13 1994-03-18 Substituted aminoalkylphosphonic acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898911017A GB8911017D0 (en) 1989-05-13 1989-05-13 Substituted aminoalkylphosphinic acids

Publications (1)

Publication Number Publication Date
YU91790A true YU91790A (sh) 1992-07-20

Family

ID=10656689

Family Applications (1)

Application Number Title Priority Date Filing Date
YU91790A YU91790A (sh) 1989-05-13 1990-05-10 Postopek za pripravo substituiranih aminoalkilfosfinskih kislin

Country Status (24)

Country Link
EP (1) EP0399949B1 (sh)
JP (1) JP2930366B2 (sh)
KR (1) KR0159501B1 (sh)
AT (1) ATE121095T1 (sh)
AU (1) AU629335B2 (sh)
CA (1) CA2016631C (sh)
DD (1) DD294265A5 (sh)
DE (1) DE69018514T2 (sh)
DK (1) DK0399949T3 (sh)
ES (1) ES2070303T3 (sh)
FI (1) FI94416C (sh)
GB (1) GB8911017D0 (sh)
GR (1) GR3015770T3 (sh)
HR (1) HRP940178A2 (sh)
HU (1) HU206885B (sh)
IE (1) IE66165B1 (sh)
IL (1) IL94317A (sh)
MX (1) MX20639A (sh)
NO (1) NO176761C (sh)
NZ (1) NZ233647A (sh)
PT (1) PT94014B (sh)
SI (1) SI9010917B (sh)
YU (1) YU91790A (sh)
ZA (1) ZA903611B (sh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0767174A1 (de) * 1991-11-21 1997-04-09 Ciba-Geigy Ag Neue Aminoalkanphosphinsäuren und ihre Salze
PL189872B1 (pl) 1996-07-24 2005-10-31 Warner Lambert Co Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu
CN1309659A (zh) 1998-07-15 2001-08-22 哈桑·朱马 有机磷化合物及其用途
GB9906882D0 (en) * 1999-03-25 1999-05-19 Novartis Ag Organic compounds
SE9904508D0 (sv) 1999-12-09 1999-12-09 Astra Ab New compounds
US7319095B2 (en) 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
SE9904507D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds
AR033779A1 (es) 2001-06-08 2004-01-07 Astrazeneca Ab Compuestos utiles en la enfermedad de reflujo
SE0102055D0 (sv) * 2001-06-08 2001-06-08 Astrazeneca Ab New Compounds
PL1691811T3 (pl) 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
SE0401653D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab New compounds
KR20080087852A (ko) 2005-12-23 2008-10-01 아스트라제네카 아베 Gaba-b 수용체 조절제
JP2009521428A (ja) 2005-12-23 2009-06-04 アストラゼネカ・アクチエボラーグ 胃腸疾患治療用のイミダゾール誘導体
DE102008056228A1 (de) * 2008-11-06 2010-05-12 Clariant International Limited Verfahren zur Herstellung von monoaminofunktionalisierten Dialkylphosphinsäuren, deren Salze und Ester und ihre Verwendung
DE102008056339A1 (de) * 2008-11-07 2010-05-12 Clariant International Limited Verfahren zur Herstellung von mono-aminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung
WO2011113904A1 (en) 2010-03-17 2011-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
WO2012050907A2 (en) 2010-09-28 2012-04-19 The Regents Of The University Of California Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3311475C1 (de) * 1983-03-29 1984-08-16 Siemens AG, 1000 Berlin und 8000 München Mikroprogramm-Steuereinrichtung
DE3312165A1 (de) * 1983-04-02 1984-10-04 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von phosphinothricin
GB8728483D0 (en) * 1987-12-04 1988-01-13 Ciba Geigy Ag Chemical compounds
GB8820266D0 (en) * 1988-08-26 1988-09-28 Smith Kline French Lab Compounds

Also Published As

Publication number Publication date
NZ233647A (en) 1992-08-26
KR0159501B1 (ko) 1999-01-15
DD294265A5 (de) 1991-09-26
HU206885B (en) 1993-01-28
HRP940178A2 (en) 1996-08-31
ES2070303T3 (es) 1995-06-01
IL94317A (en) 1997-07-13
FI94416B (fi) 1995-05-31
NO176761C (no) 1995-05-24
MX20639A (es) 1993-12-01
IE66165B1 (en) 1995-12-13
NO902109L (no) 1990-11-14
CA2016631C (en) 2000-08-29
IL94317A0 (en) 1991-03-10
EP0399949B1 (en) 1995-04-12
HU903012D0 (en) 1990-09-28
ZA903611B (en) 1991-02-27
SI9010917B (sl) 1999-10-31
DK0399949T3 (da) 1995-07-03
DE69018514D1 (de) 1995-05-18
JP2930366B2 (ja) 1999-08-03
AU629335B2 (en) 1992-10-01
FI902368A0 (fi) 1990-05-11
KR900018124A (ko) 1990-12-20
EP0399949A1 (en) 1990-11-28
NO902109D0 (no) 1990-05-11
FI94416C (fi) 1995-09-11
NO176761B (no) 1995-02-13
DE69018514T2 (de) 1995-09-21
HUT53656A (en) 1990-11-28
AU5480990A (en) 1990-11-15
CA2016631A1 (en) 1990-11-13
GB8911017D0 (en) 1989-06-28
SI9010917A (en) 1997-06-30
PT94014B (pt) 1996-12-31
PT94014A (pt) 1991-01-08
ATE121095T1 (de) 1995-04-15
GR3015770T3 (en) 1995-07-31
IE901716L (en) 1990-11-13
JPH0395195A (ja) 1991-04-19

Similar Documents

Publication Publication Date Title
YU91790A (sh) Postopek za pripravo substituiranih aminoalkilfosfinskih kislin
EP0747383A3 (en) Polyamine salts of clavulanic acid
PT89111A (pt) Processo de preparacao de analogos de camptotecina hidrossoluveis, dos seus intermediarios e de composicoes que os contem
ATE133667T1 (de) Thiazolderivate, verfahren zur ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
ATE150462T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung
SE0104334D0 (sv) Therapeutic agents
DE3272792D1 (en) Process for the preparation of 2-penem compounds
DK164937C (da) Analogifremgangsmaade til fremstilling af 1-alkyl-2-aminotetralinderivater eller farmaceutisk acceptable syreadditionssalte deraf samt 1-alkyl-2-aminotetralinderivater til anvendelse som udgangsmateriale i fremgangsmaaden
DE3870801D1 (de) Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten.
NO161620C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido(5,4-d)pyrimidin-derivater.
AU655869B2 (en) An amphoteric tricyclic compound
DE3782548D1 (de) Ergolin-ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen.
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
DE3381885D1 (de) Piperidinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
EP0318166A3 (en) Isoxazolo[4,5-c]azepine derivatives, process for their preparation and pharmaceutical compositions containing them
TH1354A (th) ออพติคัลลี่ แอคตีฟ 1-(6-เมทธอกซี-2-แนพซิล)-2-(อัลคอกซิคาร์บอนิล) อะมิโน-1-โพรพะโนน อนุพันธุ์ต่างๆ และพวกสารฮาโลของมัน และกรรมวิธีการผลิตสารเหล่านี้